[1]
Burton, C.; Ma, Y. Current trends in cancer biomarker discovery using urinary metabolomics: Achievements and new challenges. Curr. Med. Chem., 2019, 26(1), 5-28.
[2]
Kotłowska, A.; Szefer, P. Recent advances and challenges in steroid metabolomics for biomarker discovery. Curr. Med. Chem., 2019, 26(1), 29-45.
[3]
Barba, I.; Andrés, M.; Garcia-Dorado, D. Metabolomics and heart diseases: from basic to clinical approach. Curr. Med. Chem., 2019, 26(1), 46-59.
[4]
Mika, A.; Śledzinski, T.; Stepnowski, P. Current progress of lipid analysis in metabolic diseases by mass spectrometry methods. Curr. Med. Chem., 2019, 26(1), 60-103.
[5]
Spodzieja, M.; Rodziewicz-Motowidło, S.; Szymańska, A. Hyphenated mass spectrometry techniques in the diagnosis of amyloidosis. Curr. Med. Chem., 2019, 26(1), 104-120.
[6]
Chylewska, A.; Ogryzek, M.; Makowski, M. Modern approach to medical diagnostics - the use of separation techniques in microorganisms detection. Curr. Med. Chem., 2019, 26(1), 121-165.
[7]
Sadowski, R.; Gadzała-Kopciuch, R.; Buszewski, B. Recent developments in separation of low molecular weight heparin anticoagulants. Curr. Med. Chem., 2019, 26(1), 166-176.
[8]
Woźniak, M.K.; Wiergowski, M.; Namieśnik, J.; Biziuk, M. Biomarkers of alcohol consumption in body fluids - possibilities and limitations of application in toxicological analysis. Curr. Med. Chem., 2019, 26(1), 177-196.
[9]
Wojnowski, W.; Partyka, A.; Dymerski, T.; Gębickici, J.; Namieśnik, J. Electronic noses in medical diagnostics. Curr. Med. Chem., 2019, 26(1), 197-215.
[10]
Yamba-Mpang, A.; Struck-Lewicka, W.; Wawrzyniak, R.; Markuszewski, M.; Roslan, M.; Kaliszan, R.; Markuszewski, M. Metabolomic heterogeneity of urogenital tract cancers analyzed by complementary chromatographic techniques coupled with mass spectrometry. Curr. Med. Chem., 2019, 26(1), 216-231.
[11]
Wawrzyniak, R.; Yamba-Mpanga, A.; Struck-Lewicka, W.; Kordalewska, M.; Polonis, K.; Patejko, M.; Mironiuk, M.; Szyndler, A.; Chrostowska, M.; Hoffmann, M.; Smoleński, R.T.; Kaliszan, R.; Narkiewicz, K.; Markuszewski, M.J. Untargeted metabolomics provides insight into mechanisms underlying resistant hypertension. Curr. Med. Chem., 2019, 26(1), 232-243.
